Showing results (1-10 of 75) with videos related to
Sort By:
Pageof 8
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|April 4, 2022
[Improvement in Aqueous Solubility of Bioactive Molecules by Decreasing Intermolecular Interaction]Minoru IshikawaAngewandte Chemie (International Ed. in English)|May 16, 2020
PROTACs and Other Chemical Protein Degradation Technologies for the Treatment of Neurodegenerative DisordersShusuke Tomoshige, Minoru IshikawaBioorganic & Medicinal Chemistry|May 25, 2021
In vivo synthetic chemistry of proteolysis targeting chimeras (PROTACs)Shusuke Tomoshige, Minoru IshikawaThe Journal of Antibiotics|January 27, 2009
Chemical modification of pseurotin A: one-pot synthesis of synerazol and pseurotin E and determination of absolute stereochemistry of pseurotin EMinoru Ishikawa, Tomohisa NinomiyaBioscience, Biotechnology, and Biochemistry|January 25, 2005
Interaction of modified cyclodextrins with cytochrome P-450Minoru Ishikawa, Hidefumi Yoshii, Takeshi FurutaJournal of Medicinal Chemistry|October 8, 2025
Challenges of Aufheben to Promote Druglikeness: Chemical Modification Strategies to Improve Aqueous Solubility and PermeabilityMinoru Ishikawa, Shusuke Tomoshige, Shinichi SatoBioorganic & Medicinal Chemistry|May 30, 2016
Efficient protein knockdown of HaloTag-fused proteins using hybrid molecules consisting of IAP antagonist and HaloTag ligandShusuke Tomoshige, Yuichi Hashimoto, Minoru IshikawaOrganic & Biomolecular Chemistry|September 5, 2015
Degradation of HaloTag-fused nuclear proteins using bestatin-HaloTag ligand hybrid moleculesShusuke Tomoshige, Mikihiko Naito, Yuichi Hashimoto, et al.Pharmaceuticals (Basel, Switzerland)|April 25, 2020
Selective Degradation of Target Proteins by Chimeric Small-Molecular Drugs, PROTACs and SNIPERsMinoru Ishikawa, Shusuke Tomoshige, Yosuke Demizu, et al.Bioorganic & Medicinal Chemistry Letters|April 12, 2011
Non-competitive and selective dipeptidyl peptidase IV inhibitors with phenethylphenylphthalimide skeleton derived from thalidomide-related α-glucosidase inhibitors and liver X receptor antagonistsKazunori Motoshima, Kazuyuki Sugita, Yuichi Hashimoto, et al.Pageof 8